Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

This study is currently recruiting participants.
Verified November 2012 by University of California, Davis
Sponsor:
Collaborator:
The Slovenian Ministry of Higher Education, Science and Technology
Information provided by (Responsible Party):
Lavjay Butani, MD, University of California, Davis
ClinicalTrials.gov Identifier:
NCT00616317
First received: February 4, 2008
Last updated: November 30, 2012
Last verified: November 2012
  Purpose

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.


Condition
Antiphospholipid Syndrome

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Resource links provided by NLM:


Further study details as provided by University of California, Davis:

Primary Outcome Measures:
  • Long term survival [ Time Frame: 10 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: September 2006
Estimated Study Completion Date: January 2015
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   up to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pediatric Nephrology Clinic at University of California, Davis

Criteria

Inclusion Criteria:

  • 18 years of age or younger at the onset of disease
  • Presence of Vascular Thrombosis
  • UC Davis patient
  • Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Exclusion Criteria:

  • Infants born to mothers with APS
  • Infants with congenital thrombophilia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00616317

Contacts
Contact: Lavjay Butani (916) 734-8118

Locations
United States, California
UC Davis Medical Center Recruiting
Sacramento, California, United States, 95817
Sponsors and Collaborators
University of California, Davis
The Slovenian Ministry of Higher Education, Science and Technology
Investigators
Principal Investigator: Lavjay Butani, M.D. University of California, Davis
  More Information

Additional Information:
No publications provided

Responsible Party: Lavjay Butani, MD, Associate Professor, University of California, Davis
ClinicalTrials.gov Identifier: NCT00616317     History of Changes
Other Study ID Numbers: 200614666-1
Study First Received: February 4, 2008
Last Updated: November 30, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, Davis:
Antiphospholipid Syndrome

Additional relevant MeSH terms:
Antiphospholipid Syndrome
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on April 15, 2014